Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Endocrinology ; 157(7): 2595-603, 2016 07.
Article in English | MEDLINE | ID: mdl-27058814

ABSTRACT

Phthalate exposure impairs testis development and function; however, whether phthalates affect nonreproductive functions is not well understood. To investigate this, C57BL/6J mice were fed 1-500 mg di-n-butyl phthalate (DBP) in corn oil, or vehicle only, daily from 4 to 14 days, after which tissues were collected (prepubertal study). Another group was fed 1-500 mg/kg·d DBP from 4 to 21 days and then maintained untreated until 8 weeks for determination of adult consequences of prepubertal exposure. Bones were assessed by microcomputed tomography and dual-energy X-ray absorptiometry and T by RIA. DBP exposure decreased prepubertal femur length, marrow volume, and mean moment of inertia. Adult animals exposed prepubertally to low DBP doses had lower bone mineral content and bone mineral density and less lean tissue mass than vehicle-treated animals. Altered dynamics of the emerging Leydig population were found in 14-day-old animals fed 100-500 mg/kg·d DBP. Adult mice had variable testicular T and serum T and LH concentrations after prepubertal exposure and a dose-dependent reduction in cytochrome p450, family 11, subfamily A, polypeptide 1. Insulin-like 3 was detected in Sertoli cells of adult mice administered the highest dose of 500 mg/kg·d DBP prepubertally, a finding supported by the induction of insulin-like 3 expression in TM4 cells exposed to 50 µM, but not 5 µM, DBP. We propose that low-dose DBP exposure is detrimental to bone but that normal bone mineral density/bone mineral content after high-dose DBP exposure reflects changes in testicular somatic cells that confer protection to bones. These findings will fuel concerns that low-dose DBP exposure impacts health beyond the reproductive axis.


Subject(s)
Bone Density/drug effects , Dibutyl Phthalate/pharmacology , Femur/drug effects , Leydig Cells/drug effects , Sertoli Cells/drug effects , Absorptiometry, Photon , Animals , Femur/diagnostic imaging , Leydig Cells/metabolism , Luteinizing Hormone/blood , Male , Mice , Plasticizers/pharmacology , Sertoli Cells/metabolism , Testis/drug effects , Testis/metabolism , Testosterone/metabolism , X-Ray Microtomography
2.
Oncotarget ; 7(15): 19214-27, 2016 Apr 12.
Article in English | MEDLINE | ID: mdl-27036037

ABSTRACT

Ovarian cancer is a disease of older women. However, the molecular mechanisms of ovarian aging and their contribution to the pathogenesis of ovarian cancer are currently unclear. mTOR signalling is a major regulator of aging as suppression of this pathway extends lifespan in model organisms. Overactive mTOR signalling is present in up to 80% of ovarian cancer samples and is associated with poor prognosis. This study examined the role of mTOR signalling in age-associated changes in ovarian surface epithelium (OSE). Histological examination of ovaries from both aged mice and women revealed OSE cell hyperplasia, papillary growth and inclusion cysts. These pathological lesions expressed bonafide markers of ovarian cancer precursor lesions, Pax8 and Stathmin 1, and were presented with elevated mTOR signalling. To understand whether overactive mTOR signalling is responsible for the development of these pathological changes, we analysed ovaries of the Pten trangenic mice and found significant reduction in OSE lesions compared to controls. Furthermore, pharmacological suppression of mTOR signalling significantly decreased OSE hyperplasia in aged mice. Treatment with mTOR inhibitors reduced human ovarian cancer cell viability, proliferation and colony forming ability. Collectively, we have established the role of mTOR signalling in age-related OSE pathologies and initiation of ovarian cancer.


Subject(s)
Aging , Epithelium/metabolism , Ovary/metabolism , TOR Serine-Threonine Kinases/metabolism , Animals , Blotting, Western , Cell Line, Tumor , Cell Survival/drug effects , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelium/drug effects , Epithelium/pathology , Female , Humans , Hyperplasia/metabolism , Hyperplasia/prevention & control , Immunosuppressive Agents/pharmacology , Mice, Inbred C57BL , Mice, Transgenic , Ovary/pathology , PTEN Phosphohydrolase/genetics , PTEN Phosphohydrolase/metabolism , Sirolimus/pharmacology
3.
Endocrinology ; 156(6): 2254-68, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25781564

ABSTRACT

Activin production and signaling must be strictly regulated for normal testis development and function. Inhibins are potent activin inhibitors; mice lacking the inhibin-α gene (Inha-/- mice) cannot make inhibin and consequently have highly elevated activin and FSH serum concentrations and excessive activin signaling, resulting in somatic gonadal tumors and infertility. Dose-dependent effects of activin in testicular biology have been widely reported; hence, we hypothesized that male mice lacking one copy of the Inha gene would produce less inhibin and have an abnormal reproductive phenotype. To test this, we compared hormone concentrations, testis development, and sperm production in Inha+/+ and Inha+/- mice. Serum and testicular inhibin-α concentrations in adult Inha+/- mice were approximately 33% lower than wild type, whereas activin A, activin B, FSH, LH, and T were normal. Sixteen-day-old Inha+/- mice had a mixed phenotype, with tubules containing extensive germ cell depletion juxtaposed to tubules with advanced Sertoli and germ cell development. This abnormal phenotype resolved by day 28. By 8 weeks, Inha+/- testes were 11% larger than wild type and supported 44% greater daily sperm production. By 26 weeks of age, Inha+/- testes had distinct abnormalities. Although still fertile, Inha+/- mice had a 27% reduction in spermatogenic efficiency, a greater proportion of S-phase Sertoli cells and lower Leydig cell CYP11A1 expression. This study is the first to identify an intratesticular role for inhibin/inhibin-α subunit, demonstrating that a threshold level of this protein is required for normal testis development and to sustain adult somatic testicular cell function.


Subject(s)
Haploinsufficiency/physiology , Inhibins/metabolism , Puberty/metabolism , Testis/metabolism , Testis/physiology , Activins/metabolism , Animals , Flow Cytometry , Follicle Stimulating Hormone/metabolism , Haploinsufficiency/genetics , Inhibins/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Puberty/genetics , Spermatogenesis/genetics , Spermatogenesis/physiology , Spermatozoa/metabolism , Spermatozoa/physiology
4.
Endocrinology ; 154(9): 3460-75, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23766129

ABSTRACT

Phthalates are plasticizers with widespread industrial, domestic, and medical applications. Epidemiological data indicating increased incidence of testicular dysgenesis in boys exposed to phthalates in utero are reinforced by studies demonstrating that phthalates impair fetal rodent testis development. Because humans are exposed to phthalates continuously from gestation through adulthood, it is imperative to understand what threat phthalates pose at other life stages. To determine the impact during prepuberty, we assessed the consequences of oral administration of 1 to 500 mg di-n-butyl phthalate (DBP)/kg/d in corn oil to wild-type (C57BL/6J) male mice from 4 to 14 days of age. Dose-dependent effects on testis growth correlated with reduced Sertoli cell proliferation. Histological and immunohistochemical analyses identified delayed spermatogenesis and impaired Sertoli cell maturation after exposure to 10 to 500 mg DBP/kg/d. Interference with the hypothalamic-pituitary-gonadal axis was indicated in mice fed 500 mg DBP/kg/d, which had elevated circulating inhibin but no change in serum FSH. Increased immunohistochemical staining for inhibin-α was apparent at doses of 10 to 500 mg DBP/kg/d. Serum testosterone and testicular androgen activity were lower in the 500 mg DBP/kg/d group; however, reduced anogenital distance in all DBP-treated mice suggested impaired androgen action at earlier time points. Long-term effects were evident, with smaller anogenital distance and indications of disrupted spermatogenesis in adult mice exposed prepubertally to doses from 1 mg DBP/kg/d. These data demonstrate the acute sensitivity of the prepubertal mouse testis to DBP at doses 50- to 500-fold lower than those used in rat and identify the upregulation of inhibin as a potential mechanism of DBP action.


Subject(s)
Androgens/metabolism , Dibutyl Phthalate/toxicity , Endocrine Disruptors/toxicity , Plasticizers/toxicity , Sexual Development/drug effects , Testicular Diseases/chemically induced , Testis/drug effects , Androgens/blood , Animals , Cell Proliferation/drug effects , Dibutyl Phthalate/administration & dosage , Dose-Response Relationship, Drug , Endocrine Disruptors/administration & dosage , Hypothalamo-Hypophyseal System/drug effects , Inhibins/blood , Inhibins/metabolism , Male , Mice , Mice, Inbred C57BL , Plasticizers/administration & dosage , Random Allocation , Sertoli Cells/drug effects , Sertoli Cells/metabolism , Sertoli Cells/pathology , Sexual Maturation/drug effects , Spermatogenesis/drug effects , Testicular Diseases/metabolism , Testicular Diseases/pathology , Testis/metabolism , Testis/pathology , Testosterone/blood
5.
J Cell Physiol ; 224(1): 71-83, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20232304

ABSTRACT

Recent studies from within our laboratory have demonstrated a causal relationship between capacitation-associated surface phosphotyrosine expression and the ability of mouse spermatozoa to recognize the oocyte and engage in sperm-zona pellucida interaction. In the studies described herein we have sought to investigate the signaling pathways that underpin the tyrosine phosphorylation of sperm surface protein targets and validate the physiological significance of these pathways in relation to sperm-zona pellucida adhesion. Through selective pharmacological inhibition we have demonstrated that surface phosphotyrosine expression is unlikely to be mediated by the canonical cAMP-dependent protein kinase A (PKA) signaling cascade that has been most widely studied in relation to sperm capacitation. Rather, it appears to be primarily driven by the extracellular signal-regulated kinase (ERK) module of the mitogen-activated protein kinase (MAPK) pathway. Consistent with this notion, the main components of the ERK module (RAS, RAF1, MEK, and ERK1/2) were localized to the periacrosomal region of the head of mature mouse spermatozoa and their phosphorylation status within this region of the cell was positively modulated by capacitation. Furthermore, inhibition of several elements of this pathway suppressed sperm surface phosphotyrosine expression and induced a concomitant reduction sperm-zona pellucida interaction. Collectively, these data highlight a previously unappreciated role of the ERK module in the modification of the sperm surface during capacitation to render these cells functionally competent to engage in the process of fertilization.


Subject(s)
MAP Kinase Signaling System , Phosphotyrosine/metabolism , Sperm Capacitation , Sperm-Ovum Interactions , Spermatozoa/metabolism , Animals , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/metabolism , Dose-Response Relationship, Drug , Female , MAP Kinase Kinase Kinases/antagonists & inhibitors , MAP Kinase Kinase Kinases/metabolism , MAP Kinase Signaling System/drug effects , Male , Mice , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/antagonists & inhibitors , Mitogen-Activated Protein Kinase 3/metabolism , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-raf/antagonists & inhibitors , Proto-Oncogene Proteins c-raf/metabolism , Sperm Capacitation/drug effects , Sperm-Ovum Interactions/drug effects , Spermatozoa/drug effects , Spermatozoa/enzymology , Time Factors , ras Proteins/antagonists & inhibitors , ras Proteins/metabolism
6.
J Cell Physiol ; 218(1): 122-34, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18726997

ABSTRACT

Mammalian spermatozoa acquire the ability to fertilize an oocyte as they ascend the female reproductive tract. This process is characterized by a complex cascade of biophysical and biochemical changes collectively know as "capacitation." The attainment of a capacitated state is accompanied by a dramatic reorganization of the surface architecture to render spermatozoa competent to recognize the oocyte and initiate fertilization. Emerging evidence indicates that this process is facilitated by molecular chaperone-mediated assembly of a multimeric receptor complex on the sperm surface. However, the mechanisms responsible for gathering key recognition molecules within this putative complex have yet to be defined. In this study, we provide the first evidence that chaperones partition into detergent resistant membrane fractions (DRMs) within capacitated mouse spermatozoa and co-localize in membrane microdomains enriched with the lipid raft marker, G(M1) ganglioside. During capacitation, these microdomains coalesce within the apical region of the sperm head, a location compatible with a role in sperm-zona pellucida interaction. Significantly, DRMs isolated from spermatozoa possessed the ability to selectively bind to the zona pellucida of unfertilized, but not fertilized, mouse oocytes. A comprehensive proteomic analysis of the DRM fractions identified a total of 100 proteins, a number of which have previously been implicated in sperm-oocyte interaction. Collectively, these data provide compelling evidence that mouse spermatozoa possess membrane microdomains that provide a platform for the assembly of key recognition molecules on the sperm surface and thus present an important mechanistic insight into the fundamental cell biological process of sperm-oocyte interaction.


Subject(s)
Cell Membrane/metabolism , Spermatozoa/metabolism , Animals , Detergents , Female , G(M1) Ganglioside/metabolism , In Vitro Techniques , Male , Membrane Microdomains/metabolism , Membrane Proteins/metabolism , Mice , Molecular Chaperones/metabolism , Proteomics , Sperm Capacitation/physiology , Sperm-Ovum Interactions/physiology
7.
Biol Reprod ; 78(6): 983-93, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18276932

ABSTRACT

Mammalian spermatozoa must undergo epididymal maturation in the male reproductive tract and capacitation in the female tract before acquiring the ability to fertilize an oocyte. Previous studies from our laboratory have demonstrated a causal relationship between capacitation-associated surface phosphotyrosine expression and the ability of mouse spermatozoa to recognize the oocyte and engage in sperm-zona pellucida interaction. Our previous analyses of the surface phosphoproteome of capacitated murine spermatozoa identified two molecular chaperones, heat shock protein (HSP) D1 and HSP90B1, with well-characterized roles in protein folding and the assemblage of multimeric protein complexes. The expression of these chaperones was restricted to the rostral aspect of the sperm head, in an ideal position to mediate sperm-zona pellucida interaction. Herein, we report the characterization of an additional chaperone in this location, HSPE1 (chaperonin 10; HSP10). This chaperone was identified using a coimmunoprecipitation strategy employing HSPD1 as bait. The putative interaction between HSPE1 and HSPD1 was supported by reciprocal immunoprecipitation and colocalization studies, which demonstrated the coordinated appearance of both proteins on the surface of the sperm head during capacitation. However, the surface exposure of the protein was lost upon induction of acrosomal exocytosis, as would be expected of a protein potentially involved in sperm-zona pellucida interaction. Collectively, these data invite speculation that a number of molecular chaperones are involved in modification of the sperm surface during capacitation to render these cells functionally competent to engage the process of fertilization.


Subject(s)
Chaperonin 10/physiology , Sperm Capacitation/physiology , Acrosome Reaction/physiology , Animals , Chaperonin 10/isolation & purification , Chaperonin 60/physiology , Epididymis/metabolism , Female , Fertilization/physiology , Immunoprecipitation , Male , Membrane Glycoproteins/physiology , Mice , Sperm-Ovum Interactions/physiology , Spermatozoa/metabolism , Testis/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...